Regional President, North America
Pfizer Vaccines
David Hering, MBA, is Regional President, North America, Pfizer Vaccines. Prior to this role, David was Vaccines Commercial Officer for Pfizer Vaccines global business where he was responsible for global commercial development, commercial operations, business alliances – including the partnership with Gavi, the Vaccine Alliance. Before joining Pfizer in 2015, David spent seven years at Novartis Vaccines, where he held the position of Head of the North America Region and oversaw a 275-person organization consisting of Sales, Marketing, Medical Affairs, Policy, and Distribution across a portfolio of four vaccine assets in Meningitis and Travel. In this role, David was responsible for the launch of Bexsero®, Novartis’s licensed meningococcal B vaccine. He also led the transition of Novartis Vaccines to GSK as part of the acquisition announced in April of 2014 and completed in March 2015. During the Ebola epidemic, David was selected by the CEO of Novartis to run a unified Ebola task force response and coordinate all activities across several divisions of the company, including internal and external communications, research programs, grant responses, and negotiations with governments and third parties. Prior to this role, David held positions of increasing responsibility at Novartis Vaccines, including Vice President of US Marketing, Head Medical Countermeasures (Biodefense franchise), and roles in US Sales, Product Market Access and Government Contracts, and Influenza Marketing. He also worked as a Senior Consultant at Keystone Strategy prior to joining Novartis. David started his career at Merck in Manufacturing and Finance and at 3M Company in Consumer Product Marketing. He earned a bachelor of science degree in operations research and industrial engineering from Cornell University’s College of Engineering, and a master of business administration degree from Harvard Business School.
None yet.